Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2025-12-27 @ 11:10 PM
Study NCT ID:
NCT05859334
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2023-05-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-04
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-23
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-13
First Submit QC Date:
None
Study First Post Date:
2023-05-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-23
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL